Ascendis Pharma AS (STU:A710) Institutional Ownership: 69.35% (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:A710 Ascendis Pharma AS STU:A710
46 GF Score
Price €232.00
! 3 Warning Signs
View Full Analysis

What is Ascendis Pharma AS Institutional Ownership?

Ascendis Pharma AS STU:A710 46 Institutional Ownership is 69.35% as of Sep. 07, 2026. GuruFocus rates STU:A710 with a GF Score™ of 46/100. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ascendis Pharma AS's institutional ownership is 69.35%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ascendis Pharma AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ascendis Pharma AS's Float Percentage Of Total Shares Outstanding is 0.00%.

Ascendis Pharma AS Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Ascendis Pharma AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma AS Institutional Ownership Chart

Ascendis Pharma AS Historical Data

The historical data trend for Ascendis Pharma AS can be seen below:

2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 1.04 35.75 36.92 68.82 69.32 69.35
STU:A710
46GF Score
Ascendis Pharma AS STU:A710
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Pharma AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 69.35% mean?
Ascendis Pharma AS (STU:A710) has a Institutional Ownership of 69.35% as of Sep. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Ascendis Pharma AS and its competitors.
Is Ascendis Pharma AS's Institutional Ownership too high?
Ascendis Pharma AS's current Institutional Ownership is 69.35%. Overall, Ascendis Pharma AS has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's Institutional Ownership compare to JAZZ and BBIO?
Ascendis Pharma AS's Institutional Ownership of 69.35% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Ascendis Pharma AS and its competitors. Ascendis Pharma AS's current Institutional Ownership is 69.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (STU:A710) has a current Institutional Ownership of 69.35%. The current Institutional Ownership is 69.35%. Ascendis Pharma AS's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Ascendis Pharma AS (STU:A710), the current Institutional Ownership is 69.35% as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Pharma AS Business Description

Other Exchanges ASND:USAA1SN34:Brazil
Address Tuborg Boulevard 12, Hellerup, DNK, 2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
46GF Score

Get the complete analysis for STU:A710

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€232.00
Price